OverviewChartTechnicalNewsTraderScreen

CIPHER PHARMACEUTICALS INC/  CA17253X1050  /

Toronto
02/08/2024  22:00:00 Chg. -0.21 Volume Bid22:11:00 Ask22:11:00 High Low
12.13CAD -1.70% 28,586
Turnover: 334,656.50		 12.10Bid Size: 100 12.67Ask Size: 200 12.37 12.00
Newsfile Corp 03/04 Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Co...
GlobeNewswire 29/01 OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
Newsfile Corp 18/04/2023 Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire 12/08/2021 Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Cran...
GlobeNewswire 08/08/2019 Aclaris Therapeutics Reports Second Quarter 2019 Financial Results, Provides Business Strategy Updat...
GlobeNewswire 18/03/2019 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update...
GlobeNewswire 20/07/2018 HSR Act Waiting Period Terminated for United Therapeutics’ Acquisition of SteadyMed Ltd.
GlobeNewswire 08/05/2018 Aclaris Therapeutics Reports First Quarter 2018 Financial Results and Provides Update on Clinical an...
GlobeNewswire 30/04/2018 United Therapeutics to Acquire SteadyMed Ltd.
GlobeNewswire 06/04/2018 Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercial...
GlobeNewswire 30/03/2018 SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
GlobeNewswire 25/08/2017 World Prescription Dermatological Drugs Market 2017: New Biologics and Their Uses in Dermatology / M...
GlobeNewswire 27/03/2017 Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Operational ...